Watch Demo

Luxembourg Antihypertensive Industry Outlook 2022 - 2026

See how Luxembourg Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Sales of antihypertensive medicines in Luxembourg are expected to reach $400,000 by 2026, down 1.9% annually from the 2021 figure of $440,000. Since 2000, demand has decreased by 2.5% every year. In 2021, Luxembourg was in 26th place, overtaken by Iceland with $440,000. Italy, Spain and Australia were ranked 2nd, 3rd and 4th respectively.

Luxembourg Antihypertensive Market Data and Forecasts

How much will Luxembourg Antihypertensive Market grow to 2026?

Forecast: Antihypertensive Medicine Sales in Luxembourg
Forecast: Antihypertensive Medicine Sales in Luxembourg
Forecast: Renin-Angiotensin System Medicine Sales in Luxembourg
Forecast: Renin-Angiotensin System Medicine Sales in Luxembourg
Forecast: Antihypertensive Medicine Sales in Luxembourg
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends